Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

NASDAQ:XOS - Nasdaq - US98423B3069 - Common Stock - Currency: USD

3.08  0 (0%)

Fundamental Rating

2

Overall XOS gets a fundamental rating of 2 out of 10. We evaluated XOS against 128 industry peers in the Machinery industry. Both the profitability and financial health of XOS have multiple concerns. XOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XOS has reported negative net income.
In the past year XOS has reported a negative cash flow from operations.
In the past 5 years XOS reported 4 times negative net income.
XOS had a negative operating cash flow in each of the past 5 years.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -56.27%, XOS is doing worse than 89.84% of the companies in the same industry.
The Return On Equity of XOS (-198.90%) is worse than 90.63% of its industry peers.
Industry RankSector Rank
ROA -56.27%
ROE -198.9%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

The Gross Margin of XOS (4.91%) is worse than 92.19% of its industry peers.
In the last couple of years the Gross Margin of XOS has declined.
The Profit Margin and Operating Margin are not available for XOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

2

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XOS has been increased compared to 1 year ago.
Compared to 5 years ago, XOS has less shares outstanding
The debt/assets ratio for XOS has been reduced compared to a year ago.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -3.92, we must say that XOS is in the distress zone and has some risk of bankruptcy.
XOS has a Altman-Z score of -3.92. This is amonst the worse of the industry: XOS underperforms 90.63% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that XOS is not too dependend on debt financing.
The Debt to Equity ratio of XOS (0.03) is better than 79.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.92
ROIC/WACCN/A
WACC9.34%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

XOS has a Current Ratio of 1.61. This is a normal value and indicates that XOS is financially healthy and should not expect problems in meeting its short term obligations.
XOS has a Current ratio of 1.61. This is in the lower half of the industry: XOS underperforms 69.53% of its industry peers.
A Quick Ratio of 0.77 indicates that XOS may have some problems paying its short term obligations.
With a Quick ratio value of 0.77, XOS is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.77
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

XOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.09%, which is quite impressive.
XOS shows a decrease in Revenue. In the last year, the revenue decreased by -8.13%.
Measured over the past years, XOS shows a very strong growth in Revenue. The Revenue has been growing by 117.49% on average per year.
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)-8.13%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-55.33%

3.2 Future

XOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.82% yearly.
XOS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.03% yearly.
EPS Next Y38.41%
EPS Next 2Y24.31%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue Next Year-9.74%
Revenue Next 2Y7.13%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.31%
EPS Next 3Y11.82%

More info and screens

0

5. Dividend

5.1 Amount

XOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOS INC

NASDAQ:XOS (6/16/2025, 4:30:02 PM)

3.08

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners2.79%
Inst Owner Change3.11%
Ins Owners24.65%
Ins Owner Change-0.15%
Market Cap25.59M
Analysts80
Price Target6.12 (98.7%)
Short Float %11.37%
Short Ratio6.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.84%
Min EPS beat(2)-97.18%
Max EPS beat(2)-12.49%
EPS beat(4)2
Avg EPS beat(4)-7.13%
Min EPS beat(4)-97.18%
Max EPS beat(4)49.25%
EPS beat(8)4
Avg EPS beat(8)-4.14%
EPS beat(12)7
Avg EPS beat(12)2.38%
EPS beat(16)8
Avg EPS beat(16)-6.59%
Revenue beat(2)0
Avg Revenue beat(2)-39.44%
Min Revenue beat(2)-42.74%
Max Revenue beat(2)-36.13%
Revenue beat(4)0
Avg Revenue beat(4)-29.33%
Min Revenue beat(4)-42.74%
Max Revenue beat(4)-7.02%
Revenue beat(8)2
Avg Revenue beat(8)-18.49%
Revenue beat(12)3
Avg Revenue beat(12)-17.87%
Revenue beat(16)5
Avg Revenue beat(16)-19%
PT rev (1m)-5.26%
PT rev (3m)-38.46%
EPS NQ rev (1m)-1.79%
EPS NQ rev (3m)-5.28%
EPS NY rev (1m)0%
EPS NY rev (3m)3.6%
Revenue NQ rev (1m)0.99%
Revenue NQ rev (3m)-39.9%
Revenue NY rev (1m)-2.41%
Revenue NY rev (3m)-45.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB 1.03
EV/EBITDA N/A
EPS(TTM)-5.57
EYN/A
EPS(NY)-2.78
Fwd EYN/A
FCF(TTM)-4.72
FCFYN/A
OCF(TTM)-4.69
OCFYN/A
SpS5.86
BVpS2.99
TBVpS2.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.27%
ROE -198.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.91%
FCFM N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.33%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 0.77
Altman-Z -3.92
F-Score4
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)244.18%
Cap/Depr(5y)306.81%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y38.41%
EPS Next 2Y24.31%
EPS Next 3Y11.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.13%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-55.33%
Revenue Next Year-9.74%
Revenue Next 2Y7.13%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%
EBIT growth 1Y18.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.03%
EBIT Next 3Y16.69%
EBIT Next 5Y9.51%
FCF growth 1Y68.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.21%
OCF growth 3YN/A
OCF growth 5YN/A